INVITED REVIEW
Ahead of Print

Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians


1 Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy
2 Division of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy
3 Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
4 Department of Pathology and Surgery, Faculty of Medicine, Cordoba, Spain

Correspondence Address:
Rodolfo Montironi,
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy

Login to access the Email id

Source of Support: None, Conflict of Interest: None

The Gleason grading system for prostate cancer (PCa) was developed in the 1960s by DF Gleason. Due to changes in PCa detection and treatment, the application of the Gleason grading system has changed considerably in pathology routine practice. Two consensus conferences were held in 2005 and in 2014 to update PCa Gleason grading. This review provides a summary of the changes in the grading of PCa from the original Gleason grading system to the prognostic grade grouping, as well as a discussion of the clinical significance of the percentage of Gleason patterns 4 and 5.


[FULL TEXT] [PDF]
Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Gasparrini S
    -  Cimadamore A
    -  Scarpelli M
    -  Massari F
    -  Doria A
    -  Mazzucchelli R
    -  Cheng L
    -  Lopez-Beltran A
    -  Montironi R
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed530    
    PDF Downloaded102    

Recommend this journal